Trials / Completed
CompletedNCT03284320
Retrospective Study in Sarcoma Patients
Retrospective Study to Evaluate Efficacy and Safety of Trabectedin (Yondelis®) in Sarcoma Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 514 (actual)
- Sponsor
- University Medicine Greifswald · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this trial is to evaluate efficacy and safety of treatment with Trabectedin in a large cohort of German patients with soft tissue and bone sarcomas.
Conditions
Timeline
- Start date
- 2017-04-18
- Primary completion
- 2019-12-31
- Completion
- 2021-11-01
- First posted
- 2017-09-15
- Last updated
- 2021-11-15
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03284320. Inclusion in this directory is not an endorsement.